Printer Friendly

ALBERTA SCIENCE & TECHNOLOGY LEADERSHIP AWARDS HONOR BIOMIRA

 ALBERTA SCIENCE & TECHNOLOGY LEADERSHIP AWARDS HONOR BIOMIRA
 EDMONTON, Alberta, Oct. 26 /PRNewswire/ -- Biomira Inc. (NASDAQ: BIOMF; Toronto, Montreal, Alberta: BRA), a Canadian biotechnology firm specializing in the research and development of cancer diagnostics and therapeutic products was honored Friday by the Alberta Science and Technology Leadership Awards Foundation.
 The Edmonton-based company won the coveted award for Outstanding Commercial Achievement in Alberta Science and Technology.
 "For a company as young as ours to be honored in a province-wide competition is the highest compliment to the many dedicated men and women of Biomira," said Dr. Alex McPherson, Biomira's president and chief executive officer. "We are all very proud to be recognized as being on the forefront of Canadian biotechnology."
 Biomira applies its innovative technology in the areas of Active Specific Immunotherapy; radioimmunoimaging and radioimmunotherapy; and in vitro cancer diagnostics.
 Among Biomira's new approaches for cancer treatment is a therapeutic injection, THERATOPE(R), which is designed to use proprietary synthetic, cancer-associated antigens to stimulate a patient's own immune system. The therapy is currently in phase II clinical trials in Canada and will begin phase II clinical trials in the United States in 1993.
 Additionally, Biomira is developing monoclonal antibody-based products for cancer imaging. Clinical Phase I/II trials for imaging agents designed to identify carcinomas of the breast, ovary, lung, cervix, colon/rectum and head and neck areas are underway in Canada and Germany.
 Biomira, founded in 1985, holds significant interests in H.C.S. Health Care Systems Inc. of Vancouver and ADI Diagnostics Inc. of Toronto.
 -0- 10/26/92
 /CONTACT: Jane Jack, investor relations of Biomira, 403-490-2812; or Mark Brand or David Dickstein, media relations (U.S.), of Pondel Parsons & Wilkinson, 310-207-9300, for Biomira/
 (BIOMF) CO: Biomira Inc. ST: Alberta IN: MTC SU:


LS -- LA041 -- 5110 10/26/92 19:44 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 26, 1992
Words:301
Previous Article:SEATTLE POST-INTELLIGENCER'S FASSIO WINS WORLD CITIZEN AWARD
Next Article:TRANSCANADA PIPELINES ANNOUNCES THIRD QUARTER RESULTS
Topics:


Related Articles
S.R. (BOB) BLAIR TO JOIN BOARD OF DIRECTORS OF BIOMIRA INC.
S.R. (BOB) BLAIR TO JOIN BOARD OF DIRECTORS OF BIOMIRA INC.
BIOMIRA INC. ANNOUNCES 1991 FINANCIAL RESULTS
BIOMIRA INC. ANNOUNCES THAT TWO OF ITS FOUNDERS SELL SMALL PORTION OF THEIR SHARES
BIOMIRA INC. ANNOUNCES REGULATORY APPROVAL FOR CLINICAL TRIALS IN GERMANY
BIOMIRA APPOINTS DR. LOWELL T. HARMISON TO BOARD OF DIRECTORS
BIOMIRA ANNOUNCES EXERCISE OF OPTION
BIOMIRA INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION
Biomira and Inno-Centre Alberta Create Spin-Off Company to Further Develop Liposomal Interleukin-2 Technology.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters